This Biotech Stock Could Double
This company has two new blockbuster drugs that could drive billions of dollars in sales -- and the stock could double in the process.
Whatever You Do, Don't Buy into this Emerging Market
This country looked like an exciting investment years ago, but it just hasn't panned out. Here's why I'd avoid it altogether...
Why I'm STILL Holding on to This Stock
I may have jumped the gun a bit, but the long-term potential for this stock remains intact. Here's why...
Forget China: This Country is a Much Better Investment
Companies are shifting production from China back to North America, and these stocks should be clear beneficiaries.
The World Has to Have this Resource... But There Simply Isn't Enough of It
Demand for this resource continues to boom, but there just isn't enough to go around...
3 Stocks You Should Avoid at All Costs
Believe it or not, analysts actually have a collectively bearish outlook on these three stocks. Here's why you couldn't pay me to own them...
A Low-Risk Pick for my $100,000 Real-Money Portfolio
After a heavy slate of investments, this company stands to reap major rewards and I expect this holding to do the same for my portfolio.
3 Turnaround Stocks You Should Buy NOW
If the turnaround strategies unfold according to plan, then some of these stocks could easily double from current levels.
Earn up to 8% Yields with these 3 Old-Fashioned Telecoms
Rural telecoms may not be fashionable, but their safety and generous yields can make them enticing holdings for income investors.
After a 40% Surge, This Stock Could Give it all Back
Recent news gave shares a lift, but investors are missing a few key points. Here's what you need to know...
